New article concludes US FDA restrictions hampering stem cell therapy progress

An article published this month in Thieme Journal of Knee Surgery entitled, “The Use of Biologic Agents in Athletes with Knee Injuries” concluded that “Biologic agents… are becoming the mainstay of nonoperative therapy in the high-demand athletic population.” but “…Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice.” The good…

Stem cell therapy for knees, osteoarthritis and autoimmune disorders: King Goff

King Goff received three applications of his own adipose tissue-derived stem cells over the course of 3 days for a knee injury and autoimmune issues at the Stem Cell Institute in Panama. In this video, Mr. Goff discusses conventional treatments he received before stem cells, pre-treatment symptoms, post-treatment improvements, the doctors and staff, and the…